Insider Transactions in Q1 2023 at Fibrogen Inc (FGEN)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 23
2023
|
Thane Wettig CEO |
SELL
Open market or private sale
|
Direct |
905
-0.81%
|
$16,290
$18.71 P/Share
|
|
Mar 20
2023
|
Thane Wettig CEO |
BUY
Bona fide gift
|
Indirect |
1,000
+50.0%
|
-
|
|
Mar 20
2023
|
Thane Wettig CEO |
SELL
Bona fide gift
|
Direct |
2,343
-2.12%
|
-
|
|
Mar 10
2023
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,140
-2.77%
|
$202,800
$20.2 P/Share
|
|
Mar 10
2023
|
Enrique A Conterno Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
31,589
-3.86%
|
$631,780
$20.2 P/Share
|
|
Mar 10
2023
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Open market or private sale
|
Direct |
7,606
-1.44%
|
$152,120
$20.2 P/Share
|
|
Mar 10
2023
|
Thane Wettig CEO |
SELL
Open market or private sale
|
Direct |
7,669
-3.27%
|
$153,380
$20.2 P/Share
|
|
Mar 10
2023
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,912
-2.15%
|
$98,240
$20.2 P/Share
|
|
Mar 08
2023
|
Mark Eisner EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,183
+5.29%
|
-
|
|
Mar 08
2023
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,363
-4.27%
|
$154,623
$21.16 P/Share
|
|
Mar 08
2023
|
Enrique A Conterno Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,349
+6.98%
|
-
|
|
Mar 08
2023
|
Enrique A Conterno Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
24,672
-6.48%
|
$518,112
$21.16 P/Share
|
|
Mar 08
2023
|
Christine Chung SVP, CHINA OPERATIONS |
BUY
Grant, award, or other acquisition
|
Direct |
15,137
+2.79%
|
-
|
|
Mar 08
2023
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Open market or private sale
|
Direct |
8,354
-3.21%
|
$175,434
$21.16 P/Share
|
|
Mar 08
2023
|
Thane Wettig CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,137
+6.14%
|
-
|
|
Mar 08
2023
|
Thane Wettig CEO |
SELL
Open market or private sale
|
Direct |
6,265
-5.68%
|
$131,565
$21.16 P/Share
|
|
Mar 08
2023
|
Juan Graham CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
7,567
+4.74%
|
-
|
|
Mar 08
2023
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,749
-3.77%
|
$57,729
$21.16 P/Share
|
|
Mar 02
2023
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,187
-0.68%
|
$24,927
$21.87 P/Share
|
|
Feb 21
2023
|
Christine Chung SVP, CHINA OPERATIONS |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+8.78%
|
-
|
|
Feb 21
2023
|
Juan Graham CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+25.52%
|
-
|
|
Feb 21
2023
|
Thane Wettig CEO |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+18.47%
|
-
|
|
Feb 21
2023
|
Mark Eisner EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,500
+15.76%
|
-
|
|
Feb 21
2023
|
Enrique A Conterno Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
85,300
+18.3%
|
-
|
|
Jan 06
2023
|
Enrique A Conterno Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,538
-0.52%
|
$29,222
$19.95 P/Share
|